Cell-specific inhibition of paramyxovirus maturation by proteasome inhibitors

Hitoshi Watanabe1, Yoshikazu Tanaka, Yukie Shimazu

  • 1Department of Virology, Graduate School of Biomedical Sciences, Hiroshima University 1-2-3 Kasumi, Minami-ku, Hiroshima, Japan.

Microbiology and Immunology
|September 21, 2005
PubMed

Insights

Proteasome inhibitors significantly impede Sendai virus (SeV) replication and maturation by disrupting early assembly steps. This antiviral effect is highly cell-specific and virus-specific, impacting paramyxoviruses more than orthomyxoviruses or rhabdoviruses.

Area of Science:

  • Virology
  • Cell Biology
  • Biochemistry

Background:

  • Proteasomes play crucial roles in cellular protein degradation.
  • The impact of proteasome inhibitors on paramyxovirus replication is not fully understood.
  • Investigating drug effects on viral replication aids in developing antiviral strategies.

Purpose of the Study:

  • To investigate the effects of proteasome inhibitors on Sendai virus (SeV) replication.
  • To compare these effects with those on orthomyxovirus and rhabdovirus replication.
  • To elucidate the specific stages of viral replication affected by proteasome inhibition.

Main Methods:

  • LLC-MK2 cells infected with Sendai virus (SeV) were treated with MG132, Lactacystin, and zLL.
  • Viral protein levels and infectivity were measured.
  • An SeV-like particle formation system was used to assess virus maturation.
  • Cell-specific effects were evaluated using CV1 and A549 cells.
  • Comparative studies included vesicular stomatitis virus and influenza virus A/WSN/33.

Main Results:

  • MG132 significantly reduced SeV growth in a dose-dependent manner, decreasing viral protein release and infectivity.
  • Proteasome inhibition disturbed early SeV assembly, affecting M protein and glycoprotein localization.
  • Virus maturation was impaired, as confirmed by the SeV-like particle system.
  • The susceptibility to MG132 varied significantly across different cell types (LLC-MK2, CV1, A549) and viruses (SeV, vesicular stomatitis virus, influenza virus).

Conclusions:

  • Proteasome inhibitors disrupt early Sendai virus assembly and maturation.
  • The antiviral efficacy of proteasome inhibitors is both cell-specific and virus-specific.
  • These findings highlight the potential of targeting proteasomes for antiviral therapy, with careful consideration of host cell and viral factors.

Related Concept Videos

Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...